.jpg)
.png)
All
Two new PCSK9 monoclonal antibodies have been given a nod of approval to the Food and Drug Administration (FDA). The FDA Endocrinologic and Metabolic Drugs Advisory Committee reviewed the evidence on the new class of cholesterol-lowering drugs and recommended that the FDA should approve the new... more
It is with great pride and excitement that I compose this chapter message. Conveniently, this issue of Lipid Spin falls midway through my year as President of NELA, and therefore provides a perfect opportunity to update you on where we are, and where we are going. The summer months were a time of... more
Joyce Ross is a Nurse Practitioner with a long history of treating FH patients, but she also has a personal experience with the inherited disorder. When Joyce’s husband Jerry was 43 years old, he was diagnosed with FH. Her husband’s parents both died from heart attacks at an early age. At that time... more
This issue sponsored by the Southwest Lipid Association Utilizing Clinical Lipid Specialists in the Patient-Centered Medical Home Deceivingly Elevated HDL-C—Mounting Risk Factors Overpower Presumed Protection
.panel-heading a, .panel-heading a:hover, .panel-heading a:visited { color: #ffffff; } Education The NLA's Professional Development Pathway offers an array of educational activities tailored to health care professionals at all... more
Clinical Insights: Metabolic Syndrome- A Useful Clinical Marker of Increased Risk for Type 2 Diabetes and Cardiovascular Disease
By Jennifer Brown, PhD, Everyday Health Staff Writer September is cholesterol awareness month, and a good time to get your cholesterol levels checked. If your bad cholesterol, LDL, is below 100 mg/dL and your good cholesterol, HDL, is above 40 mg/dL for... more
This issue sponsored by the Northeast Lipid Association Featuring: "Gender Differences in the Diagnosis and Treatment of the Metabolic Syndrome" and "Turner Syndrome: An Overlooked Gender-Specific Cardiovascular Risk Factor" more
Approximately 27 percent of adult Americans have elevated (≥ 150 mg/ dL) fasting triglycerides (TG).1 This commonly encountered dyslipidemia is an important indicator of the presence of atherogenic lipoprotein particles and may be considered a modifiable risk factor for cardiovascular disease.2... more
The 1985 Nobel Prize in Physiology for Medicine was awarded to two physicians from Southwestern Medical Center in Dallas, Texas. Michael Brown, MD, and Joseph Goldstein, MD, received this honor "for their discoveries concerning the regulation of cholesterol metabolism."1 They postulated that... more